Ileus: Clinical Trials

8 trials for Ileus, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

8 completed. 8 Phase 2, 1 Phase 3.

By phase and status

PhaseTrialsStatus
Phase 28Completed 8
Phase 31Completed 1

Follow Ileus: new trials by email Literature Review of Ileus trials Research Report on Ileus

Trials (filtered) newest first · largest first

All 8 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
A Study to Evaluate LB1148 for Return of Gastrointestinal Function and Adhesions in Subjects Undergoing Bowel Resection
LB1148, Placebo - Ileus, Post-Operative Adhesions
Phase 2CompletedPalisade Bio1122019-10-012024-06-21
Study to Evaluate LB1148 for Return of Gastrointestinal Function, Decrease Post-Operative Ileus
LB1148, Placebo - Ileus
Phase 2CompletedNewsoara Biopharma Co., Ltd.1312019-07-092021-09-27
Subcutaneous Methylnaltrexone Versus Placebo for Postoperative Ileus Prevention
Methylnaltrexone, Placebo - Postoperative Ileus
Phase 2CompletedOhio State University822019-02-212021-10-27
The Effect of Foeniculum Vulgare Ironing on Gastrointestinal Recovery After Colorectal Resection
Foeniculum Vulgare Seed Ironing - Colorectal Surgery, Foeniculum
Phase 2CompletedWest China Hospital3002018-10-202019-09-17
The Effects of Gum Chewing on Bowel Function Recovery Following Cesarean Section
Gum chewing - Paralytic Ileus
Phase 2 / Phase 3CompletedChiang Mai University1002010-05-012011-06-28
Efficacy, Safety, and Tolerability of JNJ-27018966 (Eluxadoline) in the Treatment of Irritable Bowel Syndrome With Diarrhea
Eluxadoline, Placebo - Irritable Bowel Syndrome
Phase 2CompletedFuriex Pharmaceuticals, Inc8072010-04-282019-10-22
Safety and Efficacy of Ipamorelin for Management of Post-Operative Ileus
Ipamorelin, placebo - Ileus
Phase 2CompletedHelsinn Therapeutics (U.S.), Inc1172008-04-012017-04-14
A Safety and Tolerability Study of Doripenem in Patients With Abdominal Infections or Pneumonia
Imipenem/cilastatin, Doripenem - Pneumonia, Ventilator-Associated, Pneumonia, Bacterial
Phase 2CompletedJohnson & Johnson Pharmaceutical Research & Development, L.L.C.1462007-10-012019-03-19

Narrower conditions

Abdominal Abscess (1)  ·  Bacterial Infections (1)  ·  Colonic Diseases (1)  ·  Colonic Diseases, Functional (1)  ·  Colonic Pseudo-Obstruction (1)  ·  Diarrhea (1)  ·  Digestive System Diseases (1)  ·  Fever (1)  ·  Gastrointestinal Diseases (1)  ·  Intestinal Diseases (1)  ·  Intestinal Pseudo-Obstruction (1)  ·  Irritable Bowel Syndrome (1)  ·  Pneumonia (1)  ·  Pneumonia, Bacterial (1)

Broader conditions

Intestinal Obstruction (8)  ·  Digestive System Diseases (7)  ·  Gastrointestinal Diseases (7)  ·  Intestinal Diseases (7)  ·  Pathological Conditions, Signs and Symptoms (2)  ·  Signs and Symptoms (2)  ·  Abscess (1)  ·  Bacterial Infections and Mycoses (1)  ·  Body Temperature Changes (1)  ·  Cross Infection (1)  ·  Disease Attributes (1)  ·  Healthcare-Associated Pneumonia (1)  ·  Iatrogenic Disease (1)  ·  Infections (1)

Interventions

Chewing Gum (1)  ·  Cilastatin, Imipenem Drug Combination (1)  ·  Doripenem (1)  ·  Exercise (1)  ·  eluxadoline (1)  ·  ipamorelin (1)  ·  methylnaltrexone (1)

Sponsors

Chiang Mai University (1)  ·  Furiex Pharmaceuticals, Inc (1)  ·  Helsinn Therapeutics (U.S.), Inc (1)  ·  Johnson & Johnson Pharmaceutical Research & Development, L.L.C. (1)  ·  Newsoara Biopharma Co., Ltd. (1)  ·  Ohio State University (1)  ·  Palisade Bio (1)  ·  West China Hospital (1)

Countries

United States (4)  ·  China (2)  ·  Thailand (1)

Top investigators

Kittipat Charoenkwan, MD (1)  ·  Mitch Jones, MD (1)  ·  Suzan Allen (1)  ·  Ziqiang Wang, MD (1)

Results publications

PMID 15351109, PMID 16850151, PMID 19610681, PMID 20334152, PMID 23583433, PMID 24813429, PMID 25331030, PMID 25819420, PMID 26867333, PMID 28167156, PMID 29067571, PMID 29621360, PMID 34798295